TY - JOUR AU - Wouters, B. J. AU - Delwel, R. PY - 2016 DA - 2016// TI - Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2015-07-604512 DO - 10.1182/blood-2015-07-604512 ID - Wouters2016 ER - TY - JOUR AU - Dohner, H. AU - Estey, E. H. AU - Amadori, S. AU - Appelbaum, F. R. AU - Buchner, T. AU - Burnett, A. K. AU - Dombret, H. AU - Fenaux, P. AU - Grimwade, D. AU - Larson, R. A. PY - 2010 DA - 2010// TI - Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-07-235358 DO - 10.1182/blood-2009-07-235358 ID - Dohner2010 ER - TY - JOUR AU - Dohner, H. AU - Weisdorf, D. J. AU - Bloomfield, C. D. PY - 2015 DA - 2015// TI - Acute Myeloid Leukemia JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMra1406184 DO - 10.1056/NEJMra1406184 ID - Dohner2015 ER - TY - JOUR AU - Komanduri, K. V. AU - Levine, R. L. PY - 2016 DA - 2016// TI - Diagnosis and therapy of acute myeloid leukemia in the era of molecular risk stratification JO - Annu Rev Med VL - 67 UR - https://doi.org/10.1146/annurev-med-051914-021329 DO - 10.1146/annurev-med-051914-021329 ID - Komanduri2016 ER - TY - JOUR AU - Tallman, M. S. AU - Gilliland, D. G. AU - Rowe, J. M. PY - 2005 DA - 2005// TI - Drug therapy for acute myeloid leukemia JO - Blood VL - 106 UR - https://doi.org/10.1182/blood-2005-01-0178 DO - 10.1182/blood-2005-01-0178 ID - Tallman2005 ER - TY - JOUR AU - Delbridge, A. R. AU - Grabow, S. AU - Strasser, A. AU - Vaux, D. L. PY - 2016 DA - 2016// TI - Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2015.17 DO - 10.1038/nrc.2015.17 ID - Delbridge2016 ER - TY - JOUR AU - Adams, J. M. AU - Cory, S. PY - 2018 DA - 2018// TI - The BCL-2 arbiters of apoptosis and their growing role as cancer targets JO - Cell Death Differ VL - 25 UR - https://doi.org/10.1038/cdd.2017.161 DO - 10.1038/cdd.2017.161 ID - Adams2018 ER - TY - JOUR AU - Kale, J. AU - Osterlund, E. J. AU - Andrews, D. W. PY - 2018 DA - 2018// TI - BCL-2 family proteins: changing partners in the dance towards death JO - Cell Death Differ VL - 25 UR - https://doi.org/10.1038/cdd.2017.186 DO - 10.1038/cdd.2017.186 ID - Kale2018 ER - TY - JOUR AU - Keith, F. J. AU - Bradbury, D. A. AU - Zhu, Y. M. AU - Russell, N. H. PY - 1995 DA - 1995// TI - Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C JO - Leukemia VL - 9 ID - Keith1995 ER - TY - JOUR AU - Caenepeel, S. AU - Brown, S. P. AU - Belmontes, B. AU - Moody, G. AU - Keegan, K. S. AU - Chui, D. AU - Whittington, D. A. AU - Huang, X. AU - Poppe, L. AU - Cheng, A. C. PY - 2018 DA - 2018// TI - AMG 176, a selective MCL1 inhibitor, is effective in hematologic Cancer models alone and in combination with established therapies JO - Cancer Discov VL - 8 ID - Caenepeel2018 ER - TY - JOUR AU - DiNardo, C. D. AU - Pratz, K. AU - Pullarkat, V. AU - Jonas, B. A. AU - Arellano, M. AU - Becker, P. S. AU - Frankfurt, O. AU - Konopleva, M. AU - Wei, A. H. AU - Kantarjian, H. M. PY - 2019 DA - 2019// TI - Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia JO - Blood VL - 133 UR - https://doi.org/10.1182/blood-2018-08-868752 DO - 10.1182/blood-2018-08-868752 ID - DiNardo2019 ER - TY - JOUR AU - Guieze, R. AU - Liu, V. M. AU - Rosebrock, D. AU - Jourdain, A. A. AU - Hernandez-Sanchez, M. AU - Martinez Zurita, A. AU - Sun, J. AU - Hacken, E. AU - Baranowski, K. AU - Thompson, P. A. PY - 2019 DA - 2019// TI - Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies JO - Cancer Cell VL - 36 UR - https://doi.org/10.1016/j.ccell.2019.08.005 DO - 10.1016/j.ccell.2019.08.005 ID - Guieze2019 ER - TY - JOUR AU - Nechiporuk, T. AU - Kurtz, S. E. AU - Nikolova, O. AU - Liu, T. AU - Jones, C. L. AU - D'Alessandro, A. AU - Culp-Hill, R. AU - d'Almeida, A. AU - Joshi, S. K. AU - Rosenberg, M. PY - 2019 DA - 2019// TI - The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells JO - Cancer Discov VL - 9 UR - https://doi.org/10.1158/2159-8290.CD-19-0125 DO - 10.1158/2159-8290.CD-19-0125 ID - Nechiporuk2019 ER - TY - JOUR AU - Pan, R. AU - Ruvolo, V. AU - Mu, H. AU - Leverson, J. D. AU - Nichols, G. AU - Reed, J. C. AU - Konopleva, M. AU - Andreeff, M. PY - 2017 DA - 2017// TI - Synthetic lethality of combined Bcl-2 inhibition and p53 activation in AML: mechanisms and superior Antileukemic efficacy JO - Cancer Cell VL - 32 UR - https://doi.org/10.1016/j.ccell.2017.11.003 DO - 10.1016/j.ccell.2017.11.003 ID - Pan2017 ER - TY - JOUR AU - Pan, R. AU - Ruvolo, V. R. AU - Wei, J. AU - Konopleva, M. AU - Reed, J. C. AU - Pellecchia, M. AU - Andreeff, M. AU - Ruvolo, P. P. PY - 2015 DA - 2015// TI - Inhibition of mcl-1 with the pan-Bcl-2 family inhibitor (−)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia JO - Blood VL - 126 UR - https://doi.org/10.1182/blood-2014-10-604975 DO - 10.1182/blood-2014-10-604975 ID - Pan2015 ER - TY - JOUR AU - Mazumder, S. AU - Choudhary, G. S. AU - Al-Harbi, S. AU - Almasan, A. PY - 2012 DA - 2012// TI - Mcl-1 phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-4106 DO - 10.1158/0008-5472.CAN-11-4106 ID - Mazumder2012 ER - TY - JOUR AU - Patel, S. AU - Wang, F. H. AU - Whiteside, T. L. AU - Kasid, U. PY - 1997 DA - 1997// TI - Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response JO - Oral Oncol VL - 33 UR - https://doi.org/10.1016/S0964-1955(96)00065-6 DO - 10.1016/S0964-1955(96)00065-6 ID - Patel1997 ER - TY - JOUR AU - Kumar, D. AU - Whiteside, T. L. AU - Kasid, U. PY - 2000 DA - 2000// TI - Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin- 1beta-converting enzyme-inhibitory protein JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.275.4.2973 DO - 10.1074/jbc.275.4.2973 ID - Kumar2000 ER - TY - JOUR AU - Sun, Z. AU - Liu, X. AU - Song, J. H. AU - Cheng, Y. AU - Liu, Y. AU - Jia, Y. AU - Meltzer, S. J. AU - Wang, Z. PY - 2016 DA - 2016// TI - TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy JO - Tumour Biol VL - 37 UR - https://doi.org/10.1007/s13277-016-4978-1 DO - 10.1007/s13277-016-4978-1 ID - Sun2016 ER - TY - JOUR AU - Dong, Q. AU - Fu, L. AU - Zhao, Y. AU - Xie, C. AU - Li, Q. AU - Wang, E. PY - 2017 DA - 2017// TI - TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of hippo pathway in hepatocellular carcinoma JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.14938 DO - 10.18632/oncotarget.14938 ID - Dong2017 ER - TY - JOUR AU - Lowe, J. M. AU - Nguyen, T. A. AU - Grimm, S. A. AU - Gabor, K. A. AU - Peddada, S. D. AU - Li, L. AU - Anderson, C. W. AU - Resnick, M. A. AU - Menendez, D. AU - Fessler, M. B. PY - 2017 DA - 2017// TI - The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression JO - Cell Death Differ VL - 24 UR - https://doi.org/10.1038/cdd.2016.130 DO - 10.1038/cdd.2016.130 ID - Lowe2017 ER - TY - JOUR AU - Xiao, M. AU - Xu, Q. AU - Lou, C. AU - Qin, Y. AU - Ning, X. AU - Liu, T. AU - Zhao, X. AU - Jia, S. AU - Huang, Y. PY - 2017 DA - 2017// TI - Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma JO - Hum Pathol VL - 62 UR - https://doi.org/10.1016/j.humpath.2016.12.020 DO - 10.1016/j.humpath.2016.12.020 ID - Xiao2017 ER - TY - JOUR AU - Xing, Y. AU - Liu, Y. AU - Liu, T. AU - Meng, Q. AU - Lu, H. AU - Liu, W. AU - Hu, J. AU - Li, C. AU - Cao, M. AU - Yan, S. PY - 2018 DA - 2018// TI - TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway JO - Cell Commun Signal VL - 16 UR - https://doi.org/10.1186/s12964-018-0254-x DO - 10.1186/s12964-018-0254-x ID - Xing2018 ER - TY - JOUR AU - Wu, S. AU - Li, W. AU - Wu, Z. AU - Cheng, T. AU - Wang, P. AU - Li, N. AU - Liang, X. AU - Chi, M. AU - Zhang, S. AU - Ma, Y. PY - 2019 DA - 2019// TI - TNFAIP8 promotes cisplatin resistance in cervical carcinoma cells by inhibiting cellular apoptosis JO - Oncol Lett VL - 17 ID - Wu2019 ER - TY - JOUR AU - Yang, M. AU - Zhao, Q. AU - Wang, X. AU - Liu, T. AU - Yao, G. AU - Lou, C. AU - Zhang, Y. PY - 2014 DA - 2014// TI - TNFAIP8 overexpression is associated with lymph node metastasis and poor prognosis in intestinal-type gastric adenocarcinoma JO - Histopathology VL - 65 UR - https://doi.org/10.1111/his.12413 DO - 10.1111/his.12413 ID - Yang2014 ER - TY - JOUR AU - Marsh, W. AU - Sicheri, D. AU - Center, M. S. PY - 1986 DA - 1986// TI - Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug JO - Cancer Res VL - 46 ID - Marsh1986 ER - TY - JOUR AU - Yang, C. Z. AU - Luan, F. J. AU - Xiong, D. S. AU - Liu, B. R. AU - Xu, Y. F. AU - Gu, K. S. PY - 1995 DA - 1995// TI - Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin JO - Zhongguo Yao Li Xue Bao VL - 16 ID - Yang1995 ER - TY - JOUR AU - Zhou, K. R. AU - Liu, S. AU - Sun, W. J. AU - Zheng, L. L. AU - Zhou, H. AU - Yang, J. H. AU - Qu, L. H. PY - 2017 DA - 2017// TI - ChIPBase v2.0: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data JO - Nucleic Acids Res VL - 45 UR - https://doi.org/10.1093/nar/gkw965 DO - 10.1093/nar/gkw965 ID - Zhou2017 ER - TY - JOUR AU - Tang, Z. AU - Li, C. AU - Kang, B. AU - Gao, G. AU - Li, C. AU - Zhang, Z. PY - 2017 DA - 2017// TI - GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses JO - Nucleic Acids Res VL - 45 UR - https://doi.org/10.1093/nar/gkx247 DO - 10.1093/nar/gkx247 ID - Tang2017 ER - TY - STD TI - Chanput W, Peters V, Wichers H. THP-1 and U937 Cells. In: Verhoeckx K, Cotter P, Lopez-Exposito I, Kleiveland C, Lea T, Mackie A, Requena T, Swiatecka D, Wichers H, editors. The Impact of Food Bioactives on Health: in vitro and ex vivo models. Cham (CH); 2015. p. 147–59. ID - ref30 ER - TY - JOUR AU - Sundstrom, C. AU - Nilsson, K. PY - 1976 DA - 1976// TI - Establishment and characterization of a human histiocytic lymphoma cell line (U-937) JO - Int J Cancer VL - 17 UR - https://doi.org/10.1002/ijc.2910170504 DO - 10.1002/ijc.2910170504 ID - Sundstrom1976 ER - TY - STD TI - Salaroglio IC, Mungo E, Gazzano E, Kopecka J, Riganti C. ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer. Int J Mol Sci. 2019:20(10). ID - ref32 ER - TY - JOUR AU - Zebisch, A. AU - Czernilofsky, A. P. AU - Keri, G. AU - Smigelskaite, J. AU - Sill, H. AU - Troppmair, J. PY - 2007 DA - 2007// TI - Signaling through RAS-RAF-MEK-ERK: from basics to bedside JO - Curr Med Chem VL - 14 UR - https://doi.org/10.2174/092986707780059670 DO - 10.2174/092986707780059670 ID - Zebisch2007 ER - TY - JOUR AU - Lunghi, P. AU - Tabilio, A. AU - Dall'Aglio, P. P. AU - Ridolo, E. AU - Carlo-Stella, C. AU - Pelicci, P. G. AU - Bonati, A. PY - 2003 DA - 2003// TI - Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts JO - Leukemia VL - 17 UR - https://doi.org/10.1038/sj.leu.2403032 DO - 10.1038/sj.leu.2403032 ID - Lunghi2003 ER - TY - JOUR AU - Wu, J. AU - Wong, W. W. AU - Khosravi, F. AU - Minden, M. D. AU - Penn, L. Z. PY - 2004 DA - 2004// TI - Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-0866 DO - 10.1158/0008-5472.CAN-04-0866 ID - Wu2004 ER - TY - JOUR AU - Ricciardi, M. R. AU - McQueen, T. AU - Chism, D. AU - Milella, M. AU - Estey, E. AU - Kaldjian, E. AU - Sebolt-Leopold, J. AU - Konopleva, M. AU - Andreeff, M. PY - 2005 DA - 2005// TI - Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia JO - Leukemia VL - 19 UR - https://doi.org/10.1038/sj.leu.2403859 DO - 10.1038/sj.leu.2403859 ID - Ricciardi2005 ER - TY - JOUR AU - Bardet, V. AU - Tamburini, J. AU - Ifrah, N. AU - Dreyfus, F. AU - Mayeux, P. AU - Bouscary, D. AU - Lacombe, C. PY - 2006 DA - 2006// TI - Single cell analysis of phosphoinositide 3-kinase/Akt and ERK activation in acute myeloid leukemia by flow cytometry JO - Haematologica VL - 91 ID - Bardet2006 ER - TY - JOUR AU - Xue, L. AU - Pulikkan, J. A. AU - Valk, P. J. AU - Castilla, L. H. PY - 2014 DA - 2014// TI - NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfbeta-SMMHC via activation of MEK/ERK axis JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2013-12-541730 DO - 10.1182/blood-2013-12-541730 ID - Xue2014 ER - TY - JOUR AU - Morita, K. AU - Masamoto, Y. AU - Kataoka, K. AU - Koya, J. AU - Kagoya, Y. AU - Yashiroda, H. AU - Sato, T. AU - Murata, S. AU - Kurokawa, M. PY - 2015 DA - 2015// TI - BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4 JO - Leukemia VL - 29 UR - https://doi.org/10.1038/leu.2015.137 DO - 10.1038/leu.2015.137 ID - Morita2015 ER - TY - JOUR AU - Chaturvedi, L. S. AU - Marsh, H. M. AU - Shang, X. AU - Zheng, Y. AU - Basson, M. D. PY - 2007 DA - 2007// TI - Repetitive deformation activates focal adhesion kinase and ERK mitogenic signals in human Caco-2 intestinal epithelial cells through Src and Rac1 JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M605817200 DO - 10.1074/jbc.M605817200 ID - Chaturvedi2007 ER - TY - JOUR AU - Wang, Z. AU - Pedersen, E. AU - Basse, A. AU - Lefever, T. AU - Peyrollier, K. AU - Kapoor, S. AU - Mei, Q. AU - Karlsson, R. AU - Chrostek-Grashoff, A. AU - Brakebusch, C. PY - 2010 DA - 2010// TI - Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.95 DO - 10.1038/onc.2010.95 ID - Wang2010 ER - TY - JOUR AU - Flinder, L. I. AU - Timofeeva, O. A. AU - Rosseland, C. M. AU - Wierod, L. AU - Huitfeldt, H. S. AU - Skarpen, E. PY - 2011 DA - 2011// TI - EGF-induced ERK-activation downstream of FAK requires rac1-NADPH oxidase JO - J Cell Physiol VL - 226 UR - https://doi.org/10.1002/jcp.22563 DO - 10.1002/jcp.22563 ID - Flinder2011 ER - TY - JOUR AU - Mazalouskas, M. D. AU - Godoy-Ruiz, R. AU - Weber, D. J. AU - Zimmer, D. B. AU - Honkanen, R. E. AU - Wadzinski, B. E. PY - 2014 DA - 2014// TI - Small G proteins Rac1 and Ras regulate serine/threonine protein phosphatase 5 (PP5).Extracellular signal-regulated kinase (ERK) complexes involved in the feedback regulation of Raf1 JO - J Biol Chem VL - 289 UR - https://doi.org/10.1074/jbc.M113.518514 DO - 10.1074/jbc.M113.518514 ID - Mazalouskas2014 ER - TY - JOUR AU - Nie, T. AU - Hui, X. AU - Mao, L. AU - Nie, B. AU - Li, K. AU - Sun, W. AU - Gao, X. AU - Tang, X. AU - Xu, Y. AU - Jiang, B. PY - 2016 DA - 2016// TI - Harmine induces adipocyte thermogenesis through RAC1-MEK-ERK-CHD4 Axis JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep36382 DO - 10.1038/srep36382 ID - Nie2016 ER - TY - JOUR AU - Bright, M. D. AU - Clarke, P. A. AU - Workman, P. AU - Davies, F. E. PY - 2018 DA - 2018// TI - Oncogenic RAC1 and NRAS drive resistance to endoplasmic reticulum stress through MEK/ERK signalling JO - Cell Signal VL - 44 UR - https://doi.org/10.1016/j.cellsig.2018.01.004 DO - 10.1016/j.cellsig.2018.01.004 ID - Bright2018 ER - TY - JOUR AU - Aleksakhina, S. N. AU - Kashyap, A. AU - Imyanitov, E. N. PY - 2019 DA - 2019// TI - Mechanisms of acquired tumor drug resistance JO - Biochim Biophys Acta Rev Cancer VL - 1872 UR - https://doi.org/10.1016/j.bbcan.2019.188310 DO - 10.1016/j.bbcan.2019.188310 ID - Aleksakhina2019 ER - TY - STD TI - Sillar JR, Enjeti AK. Targeting Apoptotic Pathways in Acute Myeloid Leukaemia. Cancers (Basel). 2019;11(11):1660. ID - ref47 ER - TY - JOUR AU - Huang, X. AU - Brown, C. AU - Ni, W. AU - Maynard, E. AU - Rigby, A. C. AU - Oettgen, P. PY - 2006 DA - 2006// TI - Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-08-3206 DO - 10.1182/blood-2005-08-3206 ID - Huang2006 ER - TY - JOUR AU - Xiang, P. AU - Lo, C. AU - Argiropoulos, B. AU - Lai, C. B. AU - Rouhi, A. AU - Imren, S. AU - Jiang, X. AU - Mager, D. AU - Humphries, R. K. PY - 2010 DA - 2010// TI - Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1 JO - Exp Hematol VL - 38 UR - https://doi.org/10.1016/j.exphem.2010.06.006 DO - 10.1016/j.exphem.2010.06.006 ID - Xiang2010 ER - TY - JOUR AU - Chen, C. H. AU - Su, L. J. AU - Tsai, H. T. AU - Hwang, C. F. PY - 2019 DA - 2019// TI - ELF-1 expression in nasopharyngeal carcinoma facilitates proliferation and metastasis of cancer cells via modulation of CCL2/CCR2 signaling JO - Cancer Manag Res VL - 11 UR - https://doi.org/10.2147/CMAR.S196355 DO - 10.2147/CMAR.S196355 ID - Chen2019 ER - TY - STD TI - Wang L, Tang D, Wu T, Sun F. ELF1-mediated LUCAT1 promotes choroidal melanoma by modulating RBX1 expression. Cancer Med. 2020;9:2160–70. ID - ref51 ER - TY - JOUR AU - Weisberg, E. AU - Meng, C. AU - Case, A. AU - Sattler, M. AU - Tiv, H. L. AU - Gokhale, P. C. AU - Buhrlage, S. AU - Wang, J. AU - Gray, N. AU - Stone, R. PY - 2020 DA - 2020// TI - Evaluation of ERK as a therapeutic target in acute myelogenous leukemia JO - Leukemia VL - 34 UR - https://doi.org/10.1038/s41375-019-0552-3 DO - 10.1038/s41375-019-0552-3 ID - Weisberg2020 ER - TY - STD TI - Cremer A, Ellegast JM, Alexe G, Frank ES, Ross L, Chu SH, Pikman Y, Robichaud A, Goodale A, Haupl B, et al. Resistance mechanisms to SYK inhibition in acute myeloid leukemia. Cancer Discov. 2020;10(2):214–31. ID - ref53 ER - TY - JOUR AU - Chen, S. AU - Li, H. AU - Li, S. AU - Yu, J. AU - Wang, M. AU - Xing, H. AU - Tang, K. AU - Tian, Z. AU - Rao, Q. AU - Wang, J. PY - 2016 DA - 2016// TI - Rac1 GTPase promotes interaction of hematopoietic stem/progenitor cell with niche and participates in leukemia initiation and maintenance in mouse JO - Stem Cells VL - 34 UR - https://doi.org/10.1002/stem.2348 DO - 10.1002/stem.2348 ID - Chen2016 ER - TY - JOUR AU - Wang, J. AU - Rao, Q. AU - Wang, M. AU - Wei, H. AU - Xing, H. AU - Liu, H. AU - Wang, Y. AU - Tang, K. AU - Peng, L. AU - Tian, Z. PY - 2009 DA - 2009// TI - Overexpression of Rac1 in leukemia patients and its role in leukemia cell migration and growth JO - Biochem Biophys Res Commun VL - 386 UR - https://doi.org/10.1016/j.bbrc.2009.06.125 DO - 10.1016/j.bbrc.2009.06.125 ID - Wang2009 ER - TY - JOUR AU - Wang, J. Y. AU - Yu, P. AU - Chen, S. AU - Xing, H. AU - Chen, Y. AU - Wang, M. AU - Tang, K. AU - Tian, Z. AU - Rao, Q. AU - Wang, J. PY - 2013 DA - 2013// TI - Activation of Rac1 GTPase promotes leukemia cell chemotherapy resistance, quiescence and niche interaction JO - Mol Oncol VL - 7 UR - https://doi.org/10.1016/j.molonc.2013.05.001 DO - 10.1016/j.molonc.2013.05.001 ID - Wang2013 ER - TY - JOUR AU - Quilliam, L. A. AU - Khosravi-Far, R. AU - Huff, S. Y. AU - Der, C. J. PY - 1995 DA - 1995// TI - Guanine nucleotide exchange factors: activators of the Ras superfamily of proteins JO - Bioessays VL - 17 UR - https://doi.org/10.1002/bies.950170507 DO - 10.1002/bies.950170507 ID - Quilliam1995 ER -